Our analysis of data from the GEO database suggested that FRA-1 is transcriptionally upregulated during the progression from normal to cancerous pancreatic tissue and FRA-1 mRNA may also be upregulated as the tumor progresses to metastasis. This evidence concerns the gene FOSL1 and neoplasm.